Skip to main content

Coronavirus: Vaccination

Question for Department for Business, Energy and Industrial Strategy

UIN 147726, tabled on 2 February 2021

To ask the Secretary of State for Business, Energy and Industrial Strategy, if he will make it his policy to procure a vaccine against covid-19 which has not involved the use of human embryo cells in its development; if he will encourage the use of (a) adult stem cells and (b) synthetic methods in vaccine development; and if he will make a statement.

Answered on

8 February 2021

The Medicines and Healthcare products Regulatory Agency (MHRA) has confirmed that the Oxford University/AstraZeneca, Moderna, and Pfizer/BioNTech COVID-19 vaccines, which have all received regulatory approval, do not contain any components of animal origin, and no foetal material is present in the final vaccine.

Named day
Named day questions only occur in the House of Commons. The MP tabling the question specifies the date on which they should receive an answer. MPs may not table more than five named day questions on a single day.